XML 37 R22.htm IDEA: XBRL DOCUMENT
v3.19.1

Shareholders' Equity | 12 Months Ended
--- | ---
Mar. 31, 2019
Stockholders' Equity Note [Abstract] |
Shareholders' Equity | Shareholders' Equity Share Capital The Company's nominal share capital is CHF 43.3 million, consisting of 173,106,620 shares with a par value of CHF 0.25 each, all of which were issued and 7,243,733 of which were held in treasury shares as of March 31, 2019. The Company's has reserved conditional capital of 25,000,000 shares for potential issuance on the exercise of rights granted under the Company's employee equity incentive plans and additional conditional capital for financing purposes, representing the issuance of up to 25,000,000 shares to cover any conversion rights under a future convertible bond issuance. This conditional capital was created in order to provide financing flexibility for future expansion, investments or acquisitions. During the 2018 Annual General Meeting, the shareholders of the Company authorized the Board of Directors to issue up to an additional 34,621,324 shares of the Company until September 5, 2020. Dividends Pursuant to Swiss corporate law, the payment of dividends is limited to certain amounts of unappropriated retained earnings (CHF 940.9 million or $945.2 million based on the exchange rate at March 31, 2019) and is subject to shareholder approval. In May 2019, the Board of Directors recommended that the Company pay CHF 121.8 million ($122.4 million based on the exchange rate on March 31, 2019) in cash dividends for fiscal year 2019. In September 2018, the Company declared and paid cash dividends of CHF 0.67 (USD equivalent of $0.69) per common share, totaling $114.0 million on the Company's outstanding common stock. In September 2017, the Company declared and paid cash dividends of CHF 0.61 (USD equivalent of $0.63) per common share, totaling approximately $104.2 million in U.S. Dollars, on the Company’s outstanding common stock. In September 2016, the Company declared and paid cash dividends of CHF 0.56 (USD equivalent of $0.57) per common share, totaling approximately $93.1 million in U.S. Dollars, on the Company’s outstanding common stock. Any future dividends will be subject to the approval of the Company's shareholders. Legal Reserves Under Swiss corporate law, a minimum of 5% of the Company's annual net income must be retained in a legal reserve until this legal reserve equals 20% of the Company's issued and outstanding aggregate par value per share capital. These legal reserves represent an appropriation of retained earnings that are not available for distribution and totaled $9.6 million at March 31, 2019 (based on the exchange rate at March 31, 2019). Share Repurchases In March 2014, the Company's Board of Directors approved the 2014 share buyback program, which authorizes the Company to use up to $250.0 million to purchase its own shares. This share buyback program expired in April 2017. In March 2017, the Company's Board of Directors approved the 2017 share buyback program, which authorizes the Company to use up to $250.0 million to purchase its own shares following the expiration date of 2014 buyback program. The Company's share buyback program is expected to remain in effect for a period of three years. Shares may be repurchased from time to time on the open market, through block trades or otherwise. Purchases may be started or stopped at any time without prior notice depending on market conditions and other factors. As of March 31, 2019, $187.4 million is still available for repurchase under the 2017 buyback program. A summary of the approved and active share buyback program is shown in the following table (in thousands, excluding transaction costs):
|  | Approved |  | Repurchased
Share Buyback Program |  | Shares (1) |  | Amounts |  | Shares |  | Amounts
March 2014 |  | 17,311 |  |  | $ | 250,000 |  |  | 9,113 |  |  | $ | 155,983 |
March 2017 |  | 17,311 |  |  | $ | 250,000 |  |  | 1,651 |  |  | $ | 62,567 |
(1) The approval of each of the share buyback programs by the Swiss Takeover Board limits the number of shares that the Company may repurchase to no more than 10% of its authorized share capital and voting rights. Accumulated Other Comprehensive Loss The components of accumulated other comprehensive loss were as follows (in thousands):
|  | Accumulated Other Comprehensive Income (Loss)
|  | Cumulative Translation Adjustment (1) |  | Defined Benefit Plans(1) |  | Deferred Hedging Gains (Losses) |  | Total
March 31, 2018 |  | $ | (83,848 | ) |  | $ | (6,398 | ) |  | $ | (3,209 | ) |  | $ | (93,455 | )
Other comprehensive income (loss) |  | (8,300 | ) |  | (7,534 | ) |  | 3,591 |  |  | (12,243 | )
March 31, 2019 |  | $ | (92,148 | ) |  | $ | (13,932 | ) |  | $ | 382 |  |  | $ | (105,698 | )
_______________________________________ (1) Tax effect was not significant as of March 31, 2019 or 2018. There was a $0.5 million reclassification of currency translation loss included in other income (expense), net for the year ended March 31, 2019 due to the liquidation of one of the Company's subsidiaries.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration